Clinical Anesthesia Procedures
Neuromuscular Blockade - Introduction
The principal pharmacologic effect of neuromuscular-blocking drugs (NMBDs) is to interrupt transmission of synaptic signaling at the neuromuscular junction (NMJ) by interacting with the nicotinic acetylcholine receptor (AChR).
Outline
Citation
Pino, Richard M., editor. "Neuromuscular Blockade - Introduction." Clinical Anesthesia Procedures, 9th ed., Wolters Kluwer, 2019. Anesthesia Central, anesth.unboundmedicine.com/anesthesia/view/ClinicalAnesthesiaProcedures/728493/all/Neuromuscular_Blockade___Introduction.
Neuromuscular Blockade - Introduction. In: Pino RMR, ed. Clinical Anesthesia Procedures. Wolters Kluwer; 2019. https://anesth.unboundmedicine.com/anesthesia/view/ClinicalAnesthesiaProcedures/728493/all/Neuromuscular_Blockade___Introduction. Accessed January 21, 2025.
Neuromuscular Blockade - Introduction. (2019). In Pino, R. M. (Ed.), Clinical Anesthesia Procedures (9th ed.). Wolters Kluwer. https://anesth.unboundmedicine.com/anesthesia/view/ClinicalAnesthesiaProcedures/728493/all/Neuromuscular_Blockade___Introduction
Neuromuscular Blockade - Introduction [Internet]. In: Pino RMR, editors. Clinical Anesthesia Procedures. Wolters Kluwer; 2019. [cited 2025 January 21]. Available from: https://anesth.unboundmedicine.com/anesthesia/view/ClinicalAnesthesiaProcedures/728493/all/Neuromuscular_Blockade___Introduction.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Neuromuscular Blockade - Introduction
ID - 728493
ED - Pino,Richard M,
BT - Clinical Anesthesia Procedures
UR - https://anesth.unboundmedicine.com/anesthesia/view/ClinicalAnesthesiaProcedures/728493/all/Neuromuscular_Blockade___Introduction
PB - Wolters Kluwer
ET - 9
DB - Anesthesia Central
DP - Unbound Medicine
ER -
